enalaprilat
This page covers all enalaprilat drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin-converting enzyme.
Targets
Marketed (1)
- Vasotec · Biovail Labs Intl · Cardiovascular
Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.
Patent intelligence
- enalaprilat patent landscape — aggregated cliff calendar, attackable patents, originator estates